Client: Fortune 500 Life Sciences Manufacturer.
Objective: A leading life sciences manufacturer sought to increase engagement and adherence among new patients using a cholesterol-lowering medication. The manufacturer faced significant challenges, including a high void rate where 18% of new patients did not pick up their first prescription, and a “oneand- done” phenomenon where 23.4% of new patients did not refill after their first prescription....